Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)

Market Cap	2.16B +42.7%
Revenue (ttm)	113.23M +40.1%
Net Income	-173.47M
EPS	-1.41
Shares Out	123.20M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	642,107
Average Volume	1,435,029
Open	17.60
Previous Close	17.54
Day's Range	17.36 - 17.84
52-Week Range	9.98 - 31.20
Beta	0.14
RSI	42.59
Earnings Date	Apr 23, 2026

About SHA:688670

Jiangsu Gdk Biological Technology Co., Ltd engages in the research, development, production, and sale of human vaccines. The company offers quadrivalent influenza virus split vaccines. Its human vaccine products are used for the prevention of various infectious diseases, including influenza, rabies, chickenpox, herpes zoster, and pneumonia. The company was founded in 2008 and is based in Taizhou, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 449
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688670

Financial Performance

In 2025, SHA:688670's revenue was 113.23 million, an increase of 40.13% compared to the previous year's 80.80 million. Losses were -173.47 million, 85.5% more than in 2024.